Abbott's medical device sales hit by China curbs, supply chain issues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Abbott (ABT) tops consensus expectations despite decline in Covid-19 testing related sales
January 25, 2023 9:46 AM ESTAbbott (NYSE: ABT) shares fell Wednesday despite topping consensus expectations for profit and revenue.
The medical device firm reported adjusted fourth-quarter earnings of $1.03 per share, $0.11 better than the analyst estimate of $0.92.
Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.62 billion.... More
